Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.14 billion. The enterprise value is $875.03 million.
Important Dates
The next confirmed earnings date is Thursday, February 27, 2025, before market open.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 143.18 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 143.18M |
| Shares Outstanding | 143.18M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 45.45% |
| Float | 139.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.74 |
| PS Ratio | 5.16 |
| Forward PS | 4.36 |
| PB Ratio | 2.92 |
| P/TBV Ratio | 2.96 |
| P/FCF Ratio | 40.14 |
| P/OCF Ratio | 39.72 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 1,767.73, with an EV/FCF ratio of 30.93.
| EV / Earnings | n/a |
| EV / Sales | 3.97 |
| EV / EBITDA | 1,767.73 |
| EV / EBIT | n/a |
| EV / FCF | 30.93 |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.23.
| Current Ratio | 5.60 |
| Quick Ratio | 4.89 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 67.84 |
| Debt / FCF | 3.11 |
| Interest Coverage | -3.81 |
Financial Efficiency
Return on equity (ROE) is -5.78% and return on invested capital (ROIC) is -2.48%.
| Return on Equity (ROE) | -5.78% |
| Return on Assets (ROA) | -2.15% |
| Return on Invested Capital (ROIC) | -2.48% |
| Return on Capital Employed (ROCE) | -4.04% |
| Revenue Per Employee | $734,537 |
| Profits Per Employee | -$75,173 |
| Employee Count | 300 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.43 |
Taxes
In the past 12 months, AUPH has paid $2.41 million in taxes.
| Income Tax | 2.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.86% in the last 52 weeks. The beta is 1.23, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +41.86% |
| 50-Day Moving Average | 8.44 |
| 200-Day Moving Average | 6.98 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 1,045,179 |
Short Selling Information
The latest short interest is 9.39 million, so 6.56% of the outstanding shares have been sold short.
| Short Interest | 9.39M |
| Short Previous Month | 7.48M |
| Short % of Shares Out | 6.56% |
| Short % of Float | 6.71% |
| Short Ratio (days to cover) | 6.79 |
Income Statement
In the last 12 months, AUPH had revenue of $220.36 million and -$22.55 million in losses. Loss per share was -$0.16.
| Revenue | 220.36M |
| Gross Profit | 169.36M |
| Operating Income | -19.04M |
| Pretax Income | -48.10M |
| Net Income | -22.55M |
| EBITDA | 495,000 |
| EBIT | -19.04M |
| Loss Per Share | -$0.16 |
Full Income StatementBalance Sheet
The company has $348.24 million in cash and $87.85 million in debt, giving a net cash position of $260.38 million or $1.82 per share.
| Cash & Cash Equivalents | 348.24M |
| Total Debt | 87.85M |
| Net Cash | 260.38M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 388.00M |
| Book Value Per Share | 2.71 |
| Working Capital | 361.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $28.59 million and capital expenditures -$299,000, giving a free cash flow of $28.29 million.
| Operating Cash Flow | 28.59M |
| Capital Expenditures | -299,000 |
| Free Cash Flow | 28.29M |
| FCF Per Share | $0.20 |
Full Cash Flow StatementMargins
Gross margin is 76.86%, with operating and profit margins of -8.64% and -10.23%.
| Gross Margin | 76.86% |
| Operating Margin | -8.64% |
| Pretax Margin | -9.14% |
| Profit Margin | -10.23% |
| EBITDA Margin | 0.22% |
| EBIT Margin | -8.64% |
| FCF Margin | 12.84% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.41% |
| Shareholder Yield | -0.41% |
| Earnings Yield | -1.99% |
| FCF Yield | 2.49% |
Dividend DetailsAnalyst Forecast
The average price target for AUPH is $10.33, which is 30.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.33 |
| Price Target Difference | 30.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 18.91% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 0.02:1.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.02:1 |
Scores
AUPH has an Altman Z-Score of 2.22 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.22 |
| Piotroski F-Score | 4 |